Please login to the form below
Roche Diagnostics
This page shows the latest Roche Diagnostics news and features for those working in and with pharma, biotech and healthcare.
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
Roche has announced a partnership with Eli Lilly aimed at developing a blood test for Alzheimer’s disease which, if approved, could help streamline the journey to diagnosis for more patients. ... Matt Sause, chief executive officer of Roche Diagnostics,
Latest news
-
Roche launches two antibodies to identify mutation status in brain cancer patients
Roche has announced the launch of two new antibodies to identify key mutations in patients diagnosed with brain cancer, allowing clinicians to quickly determine the best treatment path for a specific ... Matt Sause, chief executive officer of Roche
-
Roche’s high-throughput monkeypox test approved for emergency use by FDA
The tests will be conducted on Roche's 6800/8800 cobas systems, which can also detect HIV, as well as hepatitis B and C viruses. ... Thomas Schinecker, chief executive officer of Roche Diagnostics, said: “When multiple clusters of MPXV infection were
-
Roche announces launch of HPV self-sampling solution for cervical cancer screening
contribute to women not participating in screening programmes, including limited access to testing, past experiences and cultural influences, Roche outlined. ... Jonathan Keytel, head of healthcare transformation at Roche Diagnostics, said:
-
Roche launches digital PCR system to identify ultra-rare and emerging disease mutations
The diagnostics platform will allow researchers to divide DNA and RNA from an already extracted clinical sample into as many as 100, 000 microscopic individual reactions. ... Commenting on the launch, Thomas Schinecker, chief executive officer of Roche
-
Roche appoints Thomas Schinecker as new chief executive officer
He was then later appointed as Roche Diagnostics’ CEO in 2019. ... Prior to this, he served as the head of Roche Diagnostics for two years.
More from news
Approximately 7 fully matching, plus 74 partially matching documents found.
Latest Intelligence
-
Switzerland: a life sciences hub
The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... This test emerges from Roche’s diagnostics division, also headquartered in Switzerland.
-
Pharma deals in August 2015
This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery company, Constellation Pharmaceuticals. ... Exclusive global licence. 452. GeneWEAVE. Roche. Innovative clinical
-
Diagnostics are rising up the pharma value chain
Pharma interview: Anssi Pulkkinen from Roche Diagnostics, Finland on the increasing prominence of diagnostics. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.
-
Interview: AstraZeneca's Susan Galbraith
Drug discovery and development is a team sport. You can't do it really well without partnerships with academia, biotech and diagnostics companies. ... AZ is still leaving the development of companion diagnostics to external experts, however, including a
-
Deal Watch table for April 2014
570. Oryzon/ Roche (pRED). Early stage drug research pact. Oncology - LSD1 inhibitors, Orphan cancer blocker ORY-1001 (p1/2a for acute myeloid leukaemia). ... 521+. Iquum/ Roche. Acquisition. Molecular Diagnostics - Laboratory-in-a-tube (Liat) System. 450
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
VMLY&R Health welcomes Jo Crouch and Khalid Latif to senior executive team in London
Over the course of two decades, Crouch has taken on various roles, starting out in sales and marketing with Roche Diagnostics.
-
COUCH Health taps Mark Duman for chief strategy officer role
He has over 30 years of experience working in the healthcare/pharmaceutical industries, having worked with clients including AstraZeneca, the Department of Health, Johnson &Johnson, NHS England, Novartis, Roche Diagnostics and
-
Atlas Genetics appoints Jeffery Luber as CEO
Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and ... Amazon. Dr John Clarkson, founding CEO, Atlas Genetics, said:
-
Pegasus expands pharma and life sciences senior team
Prior to this, Osborn worked at LEO Pharma, Roche Diagnostics and Weber Shandwick.
-
MDxHealth creates new global commercial team
Skinner has over 30 years of international experience in senior sales and marketing positions with in-vitro diagnostic firms including Boehringer Mannheim (now Roche Diagnostics), Human Diagnostica, Bard Diagnostic Science, and ... Meanwhile, Dr
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
'Smear Word' campaign for Roche aims to break taboos and save lives
An all-female team at Mind Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test. ... She added: “From the moment we kicked off this campaign with the team at Roche Diagnostics, we
-
Winners of the HSJ Partnership Awards 2019 unveiled
Best Healthcare Provider Partnership - Roche Diagnostics and Oxford AHSN. Best Not for Profit Working in Partnership with the NHS - Breast Cancer Care, NHS Trusts and Health Boards.
-
Evoke Mind+Matter
Barrett, HealthforAnimals, Lloyds Pharmacy, Novo Nordisk, Raisio, Roche Diagnostics, Sanofi, Seqirus, SLG, Spark Therapeutics, Superdrug, Thornton &Ross, Vetoquinol, VMIC, Zogenix. ... An all-female team at Mind Matter has created a campaign for Roche
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Amgen reports positive results for Otezla in psoriatic arthritis
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
